Skip to main content

Advertisement

Table 1 Characteristics of the 39 patients with rifampicin monoresistant tuberculosis reported in France between 2005 and 2010

From: Rifampicin mono-resistant tuberculosis in France: a 2005–2010 retrospective cohort analysis

Characteristic Total History of treatment P value
N(%) No N(%) Yes N(%)
Total patients 39 (100) 20 (100) 19 (100)  
Male 19 (49) 8 (45) 11 (58) 0.63
Age median [IQR] 43 [29–58] 38.5 [24.5–58] 44 [36–58]  
≥ 40 years old 21 (54) 10 (50) 11 (58) 0.62
Foreign born patients 18 (46) 12 (60) 6 (31) 0.07
If yes, year of arrival in France:     
 < 5 years 10 8 2  
 5–10 years 4 2 2  
 ≥ 19 years 3 1 2  
NA 1 1   
Travel ≤ 2 years before diagnosis:     
Yes 10 (26) 7 (35) 3 (16) 0.38
No 25 (64) 11 (55) 14 (74)  
NA 4 2 2  
Social disadvantage 9 (23) 3 (15) 6 (30) 0.12
Collectivity 5 (13) 3 (15) 2 (10) 0.31
History of tuberculosis before diagnosis: 20 (51) 1* (5) 19 (100)  
< 5 years 15   15  
> 20 years 3 1* 2  
NA 2   2  
History of:     
-Incarceration 0 0 0 -
-Intravenous drug user 3 (8) 1 (5) 2 (10.5) 0.40
-Tuberculosis exposure 5 (13) 4 (20) 1 (5) 0.38
-Alcohol use 9 (23) 2 (10) 7 (37) 0.04
-Immunosuppression 4 (10) 3 (15) 1 (5) 0.32
HIV co-infection 9 (23) 2 (10) 7 (37) 0.04
Site of tuberculosis:     
-Pulmonary 24 (61.5) 12 (60) 12 (63) 0.94
-Extra-pulmonary 8 (20.5) 4 (20) 4 (21)  
-Pulmonary and extra-pulmonary 7 (18) 4 (20) 3 (16)  
Smear-positive 24 (62%) 7 (35%) 17 (89%) <0.001
  1. IQR: inter-quartile range; NA: not available.
  2. *: This patient did not receive any treatment.